Search research articles
Contact Us
Filters
Showing results (331-340 of 342) with videos related to
Page
of 35
Sort By:
Virchows Archiv : an International Journal of Pathology
|
February 11, 2016
In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
C G Picanço-Albuquerque, C L Morais, F L F Carvalho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 4, 2011
NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy
Jennifer A Locke, Gaetano Zafarana, Adrian S Ishkanian, et al.
Cancer
|
January 28, 2012
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
Gaetano Zafarana, Adrian S Ishkanian, Chad A Malloff, et al.
Nature Genetics
|
June 18, 2002
Mutations in SUFU predispose to medulloblastoma
Michael D Taylor, Ling Liu, Corey Raffel, et al.
The Prostate
|
May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
Dean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib
Mark Agulnik, Gilda da Cunha Santos, David Hedley, et al.
BMC Urology
|
September 12, 2018
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
Véronique Ouellet, Armen Aprikian, Alain Bergeron, et al.
The Journal of Pathology
|
May 1, 2019
Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis
Juliana Y Sakita, Michael Bader, Emerson S Santos, et al.
Journal of the National Cancer Institute
|
March 5, 2020
Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN)
Tamara Jamaspishvili, Palak G Patel, Yi Niu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Tamara L Lotan, Wei Wei, Olga Ludkovski, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 342) with videos related to
Sort By:
Page
of 35
Virchows Archiv : an International Journal of Pathology
|
February 11, 2016
In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
C G Picanço-Albuquerque, C L Morais, F L F Carvalho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 4, 2011
NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy
Jennifer A Locke, Gaetano Zafarana, Adrian S Ishkanian, et al.
Cancer
|
January 28, 2012
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
Gaetano Zafarana, Adrian S Ishkanian, Chad A Malloff, et al.
Nature Genetics
|
June 18, 2002
Mutations in SUFU predispose to medulloblastoma
Michael D Taylor, Ling Liu, Corey Raffel, et al.
The Prostate
|
May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
Dean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib
Mark Agulnik, Gilda da Cunha Santos, David Hedley, et al.
BMC Urology
|
September 12, 2018
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
Véronique Ouellet, Armen Aprikian, Alain Bergeron, et al.
The Journal of Pathology
|
May 1, 2019
Serotonin synthesis protects the mouse colonic crypt from DNA damage and colorectal tumorigenesis
Juliana Y Sakita, Michael Bader, Emerson S Santos, et al.
Journal of the National Cancer Institute
|
March 5, 2020
Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN)
Tamara Jamaspishvili, Palak G Patel, Yi Niu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Tamara L Lotan, Wei Wei, Olga Ludkovski, et al.
Page
of 35